Past and Present Hepatitis G Virus Infections in Areas Where Hepatitis C is Highly Endemic and Those Where It Is Not Endemic

ABSTRACT We reported previously on an area in Japan where over 30% of the inhabitants were positive for hepatitis C virus (HCV) antibody. In the present study, clinical features of hepatitis G virus (HGV) infection in this area of high endemicity were compared to those in an area where HCV is not endemic. A total of 400 individuals were selected randomly from those who were medically screened for liver disease in 1993; 200 were from the high-endemicity area, and the other 200 were from the no-endemicity area. HGV RNA was measured by reverse transcription and PCR with primers in the 5′ noncoding region. Antibody to HGV envelope protein E2 was measured by an enzyme-linked immunosorbent assay. Prevalence of any HGV marker in the high-endemicity area (32%) was significantly (P < 0.0001) higher than that in the no-endemicity area (6%); similar differences, 32% versus 3% (P < 0.0001), had been observed for HCV markers (HCV RNA and HCV antibody). In areas of both high and no endemicity, HCV markers were significantly more prevalent in individuals with any HGV marker than in those without HGV markers, and age-specific prevalence of HGV markers was distributed similarly to that of any HCV marker. Among possible routes of HGV transmission that were analyzed, folk medicine was significant in the high-endemicity area, but blood transfusion was the major route in the no-endemicity area. The rate of accompanying viremia in HGV infection (15%) was significantly lower than that in HCV infection (78%) (P < 0.0001). In conclusion, HGV infection was highly prevalent in the area of high HCV endemicity and was closely associated with HCV infection. HGV seemed to be transmitted via the practice of folk medicine as well as blood transfusion. HGV resulted in a chronic carrier state less frequently than did HCV.

[1]  S. Sauleda,et al.  Humoral immune response to the E2 protein of hepatitis G virus is associated with long‐term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors , 1997, Hepatology.

[2]  E. Tanaka,et al.  Hepatitis G virus/GB virus C infection in an area of high endemic hepatitis C virus infection , 1997 .

[3]  M. Lai,et al.  GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. , 1997, Gastroenterology.

[4]  R. Wesley,et al.  The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. , 1997, The New England journal of medicine.

[5]  H. Margolis,et al.  Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. , 1997, The New England journal of medicine.

[6]  K. Stark,et al.  Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.

[7]  T. Surowy,et al.  An ELISA for detection of antibodies to the E2 protein of GB virus C. , 1997, The Journal of infectious diseases.

[8]  T. Pilot‐Matias,et al.  Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. , 1996, Virology.

[9]  E. Tanaka,et al.  Effect of Hepatitis G Virus Infection on Chronic Hepatitis C , 1996, Annals of Internal Medicine.

[10]  E. Tanaka,et al.  Prevalence and disease association of hepatitis G virus infection in Japan , 1996, Journal of viral hepatitis.

[11]  J. Sheu,et al.  A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. , 1996, Blood.

[12]  H. Alter The cloning and clinical implications of HGV and HGBV-C. , 1996, The New England journal of medicine.

[13]  K. Masuko,et al.  Infection with hepatitis GB virus C in patients on maintenance hemodialysis. , 1996, New England Journal of Medicine.

[14]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[15]  T. Pilot‐Matias,et al.  Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.

[16]  T. Takayama,et al.  Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection , 1994 .

[17]  J. Chiba,et al.  Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long‐term follow‐up , 1993, Journal of medical virology.

[18]  G. Nemo,et al.  Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. , 1992, The New England journal of medicine.

[19]  G. Nemo,et al.  HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYS , 1991 .

[20]  R. Purcell,et al.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. , 1991, The New England journal of medicine.

[21]  R. Purcell,et al.  Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.

[22]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[23]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[24]  S. Yagi,et al.  Hepatitis G virus/GB virus C infection in patients with chronic non-B, non-C hepatitis , 1997 .

[25]  松本 晶博 Viral and host factors that contribute to efficacy of interferon-α[2a] therapy in patients with chronic hepatitis C , 1995 .